MedPath

Diamorphine

Generic Name
Diamorphine
Drug Type
Small Molecule
Chemical Formula
C21H23NO5
CAS Number
561-27-3
Unique Ingredient Identifier
70D95007SX

Overview

Diamorphine (heroin) is a narcotic analgesic that may be habit-forming. It is a controlled substance (opium derivative) listed in the U.S. Code of Federal Regulations, Title 21 Parts 329.1, 1308.11 (1987). Sale is forbidden in the United States by Federal statute. (Merck Index, 11th ed) Internationally, diamorphine is controlled under Schedules I and IV of the Single Convention on Narcotic Drugs. As heroin, it is illegal to manufacture, possess, or sell in the United States and the UK. However, under the name diamorphine, heroin is a legal prescription drug in the United Kingdom.

Indication

Diamorphine, as a prescription medication in the United Kingdom, is indicated for use in the treatment of severe pain associated with surgical procedures, myocardial infarction or pain in the terminally ill and for the relief of dyspnoea in acute pulmonary edema .

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2019/06/05
N/A
Completed
2014/08/06
Not Applicable
Completed
York Teaching Hospitals NHS Foundation Trust
2010/08/04
Phase 1
Completed
University Hospital, Basel, Switzerland
2010/01/14
Not Applicable
Completed
2009/04/13
Phase 4
Terminated
2008/07/04
Phase 3
Completed
2005/12/22
Phase 3
Completed
2005/09/15
Phase 3
Completed
1999/09/21
Phase 2
Withdrawn
1999/09/21
Phase 2
Withdrawn

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
DIACETYLMORPHINE HYDROCHLORIDE
02525003
Powder For Solution - Intramuscular ,  Intravenous
5000 MG / VIAL
4/11/2022
DIAMORPHINE HYDROCHLORIDE INJ 30MG/ML BP
technilab pharma inc.
00781479
Powder For Solution - Intramuscular ,  Intravenous ,  Subcutaneous
30 MG / ML
12/31/1988
DIACETYLMORPHINE HYDROCHLORIDE
02524996
Powder For Solution - Intramuscular ,  Intravenous
200 MG / VIAL
6/16/2022
DIAMORPHINE HYDROCHLORIDE INJ 100MG/ML BP
technilab pharma inc.
00781460
Powder For Solution - Intramuscular ,  Intravenous ,  Subcutaneous
100 MG / ML
12/31/1988

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.